MDNews - Eastern Pennsylvania/Northwest New Jersey

May/June 2012

Issue link: https://viewer.e-digitaledition.com/i/64389

Contents of this Issue

Navigation

Page 15 of 23

++++++++++++++++++++++++++++ + + ++++++++++++++++++++++++++++ NONPROFIT SPOTLIGHT +++ +++ I The RACE FOR ADAM Foundation By Colleen Fahey T'S BEEN A long and incredible journey for Adam Recke. While Adam was hitting all of his growth markers, as a baby, he suffered from jaundice. He then faced having an enlarged liver and spleen. Years of misdiagnosis ended on Adam's sixth birthday with the diagnosis of Niemann-Pick disease, type C (NPC), a terminal condition also referred to as childhood Alzheimer's disease that robs affected children of the ability to walk, talk, and eat. "Adam seemed perfectly healthy except for his enlarged spleen. We couldn't imagine how he could have a terminal illness," says Sean Recke, Adam's father. "The doctors said there was nothing they could do. With limited options, we were able to get Adam on a trial medication called miglustat [Zavesca] — 100mg three times a day." NPC affects fewer than 500 people in the world and only 150 in the United States. Given the rarity of the condition, funding, research, and U.S. Food and Drug Administration drug approval remain a challenge. Adam has been taking Zavesca for the past six years. Although consid- ered experimental by the FDA for treatment of Niemann-Pick disease, a few families have been given the opportunity to share their opinions on why the FDA should approve Zavesca for this condition. At this time, the FDA is still reviewing additional information. Adam Recke Finding Hope After Adam's diagnosis, Recke shared the news with the principal and assistant principal at Salisbury Middle School, where he works. "The disbelief was widespread as everyone learned about Adam, and within a short time, they rallied together to start The Race For Adam Foundation. The goal was simple — raise funds to research a cure for Adam and other children with NPC," says Recke. Adam is now in seventh grade at East Hills Middle School, a huge ordeal for normal students and an even bigger hurdle for Adam. "The staff at East Hills is wonderful, and Adam is enjoying his middle school experience. We would like to thank 'Adam's Army,' a group of teachers who have gone above and beyond our expecta- tions to help Adam. We will be forever grateful," says Recke. Adam is part of a National History Study at the National Institutes of Health (NIH). He visits once a year to be evalu- ated and could be selected for a promising compound called Cyclodextrin that will soon be tested at the NIH. "Our family is part of SOAR [Support Of Accelerated Research]. Along with a few other families, we are raising funds to support our own researchers. SOAR is funding four research labs that are trying to expedite FDA-approved compounds we can use to save our children. Additionally, SOAR has helped create a simple blood test to help with earlier diagnosis. SOAR also helps with Therapeutics for Rare and Neglected Diseases, a program through the NIH and the NIH Chemical Genomics Center," says Recke. The Race for Adam Foundation benefits from many events held throughout the year. The Seventh Annual 5K Walk/Run for a Cure at Lehigh Parkway in Allentown, PA, on May 5, and the 6th Annual Poker Ride and Family Picnic on August 25 at Schnecksville Fire Company are two upcoming events. "We are grateful to so many people. Our family's strength and hope helps us believe that someday there will be a cure. We continue to look for miracles every day," says Recke. For more information about Adam, The Race For Adam Foundation, upcoming events, sponsorship opportunities or to make a donation, please visit www.RaceForAdam.org. ■ 16 | Eastern Pennsylvania/NW New Jersey MD NEWS ■ MDNEWS.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - May/June 2012